A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of Flu Vaccine (Surface Antigen, Inactivated, Formulation 2010-2011) When Administered to Non-elderly Adult and Elderly Subjects.

Trial Profile

A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of Flu Vaccine (Surface Antigen, Inactivated, Formulation 2010-2011) When Administered to Non-elderly Adult and Elderly Subjects.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Mar 2012

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 10 May 2011 Additional lead trial centre identified as reported by European Clinical Trials Database record.
    • 10 May 2011 New source identified and integrated (European Clinical Trials Database record EudraCT2010-018583-17).
    • 06 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top